Technology Development

Expert Driven Drug Development

Technology Development is at the Core of our Mission

Landmark Bio was conceived to accelerate life sciences innovation and translate groundbreaking research into life-changing therapies. With Harvard and MIT as academic founding partners, Landmark Bio has unparalleled access to the latest transformational research. State-of-the-art technologies and network capabilities bring our innovation to life with the backing of our industrial founding partners Cytiva and FUJIFILM Diosynth Biotechnologies.

Landmark’s Technology Development services have been designed to provide you with the tools needed to rapidly translate your research into a groundbreaking advanced therapy.

We welcome the opportunity to partner and help translate your groundbreaking research into a life-changing therapy

“Landmark Bio is gathering the brightest minds across academia and industry, along with leading clinicians, to develop immediate manufacturing capabilities, and to enable innovation and research.”

—Emmanuel Ligner, Landmark Bio Founding Director,
former Cytiva President and CEO

Technology Development Services

Leveraging a robust menu of services and capabilities, we partner with you in the development of a bespoke plan to meet your program milestones and goals. These services include:

  • Product prototyping, optimization, application, productization, integration, etc.
  • Technology analysis and options
  • Product feasibility assessments
  • Development of therapeutic approach
  • Experimental design and execution in support of therapeutic and manufacturing strategies
  • Development and translation of novel therapeutic modalities into the clinic, for example: EVs, organoids, novel viral vectors, iPSCs, MSC, rare disease indications, etc.
Connect with a technology development expert
Back To Top